Logo
Friday, 29 March 2024
Thursday, 07 May 2020 10:00 am

Venturis Therapeutics, Inc. announces applications for four patents related to the use of therapeutic angiogenesis in the treatment of diseases related to the COVID-19 virus, as well as diseases related to other viruses

In the last few months, the VT team has been reviewing numerous reports and initial data from doctors around the world, concerning diseases related to lesions of epithelial cells and microvascular tissue, caused by the virus of COVID-19.

newsImage
 

Venturis Therapeutics, Inc. ("VT") announced today that it has applied for four provisional patents relating to the treatment and / or prevention of virus-induced diseases related to the COVID- 19, as well as other viruses. These new patent applications include the following general areas: cardiac injury and virus-induced stroke; severe acute respiratory syndrome (SARS ); intestinal dysfunction or damage to intestinal epithelial cells; and renal dysfunction or failure.

In the last few months, the VT team has been reviewing numerous reports and initial data from doctors around the world, concerning diseases related to lesions of epithelial cells and microvascular tissue, caused by the virus of COVID-19. Lesions are recorded in patients of different age groups, during and after the apparent recovery from the COVID-19 virus and in patients who have experienced severe or only mild symptoms of the virus. The presentation of virus-induced diseases can include, without limitation, strokes, organ failure, fibrosis, sudden blood clots and ischemia of cells and tissues. VT has many years of experience in the use of therapeutic angiogenesis in the treatment and regeneration of ischemic and / or injured epithelial cells and microvascular tissues.

VT hopes that these new patents, combined with other VT patents, such as its current stroke-related patents, will allow VT to expand the development of current and discovered methods and therapies to treat potentially fatal diseases and distressing, in large patient populations. With these proposed and existing patents, VT seeks to position itself at the forefront of private sector companies, which are combating the devastating effects of these diseases.


Neha Pandey

Aware of her elements, Neha writes the best articles across industries including electronics & semiconductors, automotive & transportation and food & beverages. Being from the finance background she has the ability to understand the dynamics of every industry and analyze the news updates to form insightful articles. Neha is an energetic person interested in music, travel, and entertainment. Since past 5 years, she written extensively on sectors like technology, finance and healthcare.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
© The News and Media Division of The Insight Partners 2024 | All Rights Reserved | Privacy Policy